# Dementia with Lewy bodies and gait neural basis: a cross-sectional study

Adele Sainsily-Cesarus, Elise Schmitt, Lionel Landré, Anne Botzung, Lucie Rauch, Catherine Demuynck, Nathalie Philippi, Paulo Loureiro de Sousa, Catherine Mutter, Benjamin Cretin, et al.

<figure><img src="image_1.png" /></figure>

## To cite this version:

Adele Sainsily-Cesarus, Elise Schmitt, Lionel Landré, Anne Botzung, Lucie Rauch, et al. Dementia with Lewy bodies and gait neural basis: a cross-sectional study. Alzheimer's Research and Therapy, 2024, 16 (1), pp.170. 10.1186/s13195-024-01539-z. hal-04969201

HAL Id: hal-04969201

https://hal.science/hal-04969201v1

Submitted on 27 Feb 2025

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_2.png" /></figure>
RESEARCH

Open Access

<figure><img src="image_3.png" /></figure>

Check for
updates

# Dementia with Lewy bodies and gait neural basis: a cross-sectional study

Adele Sainsily-Cesarus<sup>1,2†</sup>, Elise Schmitt<sup>1,3*†</sup>, Lionel Landre<sup>2</sup>, Anne Botzung<sup>1</sup>, Lucie Rauch<sup>1</sup>, Catherine Demuynck<sup>1</sup>, Nathalie Philippi<sup>1,2</sup>, Paulo Loureiro de Sousa<sup>2</sup>, Catherine Mutter<sup>4</sup>, Benjamin Cretin<sup>1,2</sup>, Catherine Martin-Hunyadi<sup>1,2</sup> and Frederic Blanc<sup>1,2</sup>

**Abstract**

**Background** Dementia with Lewy Bodies (DLB) is responsible for cognitive-behavioural disorders but also for gait disorders. The latter are thought to be related to parkinsonism, but the neural bases of these disorders are not well known, especially in the early stages. The aim of this study was to investigate by volumetric Magnetic Resonance Imaging the neuronal basis of gait disorders in DLB patients, compared to Healthy Elderly Controls and Alzheimer's Disease patients.

**Methods** Clinical examination with motor assessment including 10-meter walking speed, one-leg balance and Timed Up and Go test, a comprehensive neuropsychological evaluation and 3D brain Magnetic Resonance Imaging were performed on 84 DLB patients, 39 Alzheimer's Disease patients and 22 Healthy Elderly Controls. We used Statistical Parametric Mapping 12 to perform a one-sample t-test to investigate the correlation between each gait score and gray matter volume ($P \le 0.05$ corrected for family-wise error).

**Results** We found a correlation for DLB patients between walking speed and gray matter decrease ($P < 0.05$, corrected for family-wise error) in caudate nuclei, anterior cingulate cortex, mid-cingulate cortex, hippocampi, supplementary motor area, right cerebellar cortex and left parietal operculum. We found no correlation with Timed Up and Go test and one-leg balance.

**Conclusion** Gait disorders are underpinned by certain classical regions such as the cerebellum and the supplementary motor area. Our results suggest there may be a motivational and emotional component of voluntary gait in DLB subjects, underpinned by the cingulate cortex, a spatial orientation component, underpinned by hippocampi and suggest the involvement of brain processing speed and parkinsonism, underpinned by the caudate nuclei.

**Trial registration** The study protocol has been registered on [ClinicalTrials.gov](http://ClinicalTrials.gov). [NCT01876459](https://ClinicalTrials.gov). On June 12, 2013.

**Keywords** Dementia with lewy bodies, Walking speed, Mid-cingulate cortex, Hippocampi, Magnetic resonance imaging, Voxel-based-morphometry, VBM

<footnote>†Adele Sainsily-Cesarus and Elise Schmitt are co-first authors.</footnote>

<footnote>*Correspondence:
Elise Schmitt
elise.schmitt@chru-strasbourg.fr</footnote>

<footnote n="1">¹Geriatrics Department, University Hospital of Strasbourg, CM2R (Memory Resource and Research Centre), Strasbourg, France</footnote>

<footnote n="2">²University of Strasbourg, CNRS, UMR 7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), team IMIS, ICube laboratory, Strasbourg, France</footnote>

<footnote n="3">³Faculty of Medicine, University of Strasbourg, Strasbourg EA-3072, France</footnote>

<footnote n="4">⁴University Hospital of Strasbourg, CIC INSERM 1434, Strasbourg, France</footnote>
## Introduction

Alzheimer's disease (AD) and dementia with Lewy Bodies (DLB) are the two main cognitive neurodegenerative disorders. AD is the most common of these disorders and accounts for 50-75% of dementia [1]. DLB represents 15-20% of the neurocognitive pathologies in older people [2], but its prevalence is likely underestimated due to misdiagnosis [3].

Major neurocognitive disorder or dementia is a major risk factor for falls: it multiplies this risk by more than 10 in people over 65 years old [4]. The annual incidence of falls has been estimated at 50% in patients with dementia, which may nevertheless be underestimated as patients often do not keep track of their falls [5]. These falls can be traumatic, leading to a loss of confidence and autonomy, and often cause significant psychological trauma, accelerating institutionalization and even increasing mortality rates [6].

Falls are twice as frequent for DLB patients: in one year, almost all DLB patients fell, compared to half of AD patients [4]. Some authors explain this increased risk of falls in DLB patients by the gait and balance disorders that appear to be more marked in DLB patients than in AD subjects [5, 7]. In fact, DLB subjects have an extra-pyramidal syndrome (akinesia, rigidity) responsible for slower walking, with a marked variation in spatial and temporal parameters such as step length [7], as well as a significantly altered pace [8].

Hippocampal atrophy has long been linked to AD, but in recent years it has become apparent that this atrophy could be found in other types of dementia, including DLB, and is therefore sensitive to, but not specific to, AD [9]. The current literature proved hippocampal atrophy to cause memory disorders [10, 11] and also linked this volume loss to poor walking performance in individuals with mild cognitive impairment.

A meta-analysis using the voxel-based morphometry (VBM) method to assess atrophy in DLB patients highlighted atrophy in regions such as the insula, putamen and lateral temporal lobe [12]. The current literature focuses more on the neural basis of the brain regions involved in cognitive disorders caused by DLB, and places less emphasis on motor disorders, even though they lead to falls, including in the early stages of DLB [4]. Despite the limited literature, there appears to be a link between central gray nuclei involvement and parkinsonism [13].

The objective of this study was to investigate the neural basis of gait disorders in DLB patients, compared to healthy elderly subjects and AD patients, by using volumetric Magnetic Resonance Imaging (MRI). We hypothesized that walking disorders could be caused by the damage to the central gray nuclei associated with extrapyramidal syndrome and by the damage to frontal regions responsible for executive dysfunction.

## Population and methods

### Study population

The patients and Healthy Elderly Controls (HEC) included in this study were recruited from the Memory Resource and Research Center (CM2R) in Strasbourg, France, and were already enrolled in the AlphaLewyMA cohort (clinicaltrials.gov, NCT01876459). The initial objective of this cohort was to establish a differential diagnosis between DLB and AD based on the determination of alpha-synuclein in cerebrospinal fluid in patients with mild cognitive impairment or mild to moderate dementia [13]. Patients aged over 45 years were included in three centers: the Geriatric Day Hospital, the Neuro-psychology Unit of the University Hospital of Strasbourg, and the Geriatric Day Hospital of the Hospital of Colmar.

On inclusion in the study, each participant underwent a brain MRI and a clinical examination, including an assessment of gait, an evaluation of autonomy and neuropsychological tests. The diagnosis of AD was based on the criteria of Dubois et al. of 2007 [10] and the diagnosis of DLB was based on the revised criteria of McKeith et al. of 2005 [14]. There was no restriction on inclusion regarding the use of medication.

Patients with severe dementia (Mini-Mental State Examination (MMSE)≤9), with both diseases, with other types of dementia, other associated progressive comorbidities or vision or hearing impairments were not included [15].

### Clinical protocol

Participants with cognitive disorders were reassessed every six months while healthy elderly subjects had an annual follow-up.

At each visit, a complete neurological examination was performed, looking for parkinsonism using the UPDRS III (Unified Parkinson's Disease Rating Scale [16]) reduced to four items: bradykinesia, rigidity, tremor and facial expressions for all participants.

A motor evaluation was performed, including walking speed (10-meter walk test) assessed in a standardised walking corridor [17], the one-leg balance test [18] and the Timed Up and Go test (TUG) [19]. One-leg balance was considered successful and was rated two if the subject could balance for five seconds on each foot; performance was rated one if the subject could balance on only one foot and zero if the subject could not balance on either foot.

Falls during the previous six months were noted by the patients themselves or their caregivers, but their exact frequency was not necessarily written down.

A complete neuropsychological evaluation including an MMSE was performed annually to avoid a retest effect. Autonomy was assessed using the Instrumental Activities of Daily Living (IADL) and Activities of Daily Living
(ADL) scales. Cognitive fluctuations were assessed by the
Mayo Clinic fluctuations scale.

Study design

We decided to run a cross-sectional study and chose to
perform one visit per subject. We then selected the most
complete visit which included neurological examination,
motor evaluation (walking speed, TUG and one-leg bal-
ance), brain MRI, MMSE and IADL.

MRI acquisition

All the selected patients underwent multimodal brain
MRI, performed using a Siemens Magnetom Verio 3
Tesla device with a 32-channel probe.

The high-resolution 3D T1-weighted anatomical
sequence with an acquisition time of 7.38 min was our
sequence of interest. We used the following parameters:
an echo time of 2.53 ms, an inversion time of 900 ms, a
rotation angle of 9°, a repetition time of 1900 ms and an
isotropic voxel size of 1 mm³.

Voxel-based-morphometry (VBM)

To explore the existence of correlations between the defi-
cits observed in the different motor evaluation scores
and the concentration of Gray Matter (GM), we used
the VBM method implemented in SPM12 (Statisti-
cal Parametric Mapping 12) under Matlab R2017b (The
MathWorks, Inc., Natick, Massachusetts, US). Between-
group differences in GM volume were assessed using the

SPM12. Age, sex, and total GM volume were included in
the design matrix as covariates of no interest.

Each MR image was visualized to judge its quality.
Wherever possible, the MRI closest to the motor evalua-
tion was selected for each patient. Due to movement arti-
facts that could prevent the interpretation of some MR
images, we were sometimes forced to choose an image
acquired at a date further away from the motor evalua-
tion (without exceeding a two-year delay), or even to
eliminate patients (see Fig. 1, flowchart).

Once the selection of the best MRI image was com-
pleted, we converted the images from Digital Imaging
and Communications in Medicine to Neuroimaging
Informatics Technology Initiative format. We used the
pre-treatment and DARTEL (Diffeomorphic Anatomical
Registration Through Exponentiated Lie algebra) stages.
A spatial normalization according to the Montreal Neu-
rological Institute space (MNI) was carried out allow-
ing an affine modulation (translation, rotation, shear) to
correct the various interindividual morphological varia-
tions. The images were then segmented into six classes,
of which we selected two: gray and white matter. With
these elements, we generated a DARTEL template spe-
cific to our population, by successive distortions of indi-
vidual images. During this procedure, the individual GM
images were modulated to preserve local volume and
subjected to an 8 mm full width at half maximum Gauss-
ian filtering. Before performing the statistical analyses, a
visual check was conducted to ensure the quality of the
images and the correct delimitation of white and gray

<figure><img src="image_4.png" /><figcaption>**Fig. 1** Flowchart of the study analyzing the neural basis of gait in dementia with Lewy bodies. DLB: Dementia with Lewy bodies, AD: Alzheimer's Disease, MRI: Magnetic Resonance Imaging</figcaption></figure>
matter, particularly in the lateral ventricles and the cortical ribbon.

Three parameters of motor evaluation were tested separately as regressor, with age, sex and total GM volume in covariates.

## Statistical analyses

For the analysis of population characteristics, we conducted t-tests or Fisher's exact test. Linear regression analyses were performed to adjust walking speed for age and height using Jamovi® software. Correlation analyses were performed using Spearman's non-parametric test.

For the VBM analysis, intergroup differences were estimated with t-tests or ANOVAs, including age, sex and amount of total GM as covariates. An alpha threshold of 0.05 corrected FWE (Family-Wise Error rate) was applied at first. In the absence of significant results, the threshold was lowered by 0.001 uncorrected at the voxel level and then all results were corrected at the cluster level (P=0.05 False Discovery Rates (FDR) corrected).

## Results

### Characteristics of the subjects

Twelve participants in the DLB group had associated AD (DLB-AD). These participants had the clinical features of DLB. Given that gait disorders are often more severe in DLB patients than in AD patients [4] and that the main aim of this study was to investigate the neural basis of gait disorders in DLB patients, it was coherent to keep them in the DLB group.

Demographic, cognitive and motor characteristics are detailed in Table 1.

Mean age was higher in the AD group when compared to the DLB group (P=0.001) and the HEC group (P<0.001) (75.6 years, 70.6 years and 66.5 years respectively).

There was no significant difference in height or Body Mass Index (BMI) between the groups.

None of the participants in the HEC group were taking antiparkinsonian medication or cholinesterase inhibitors. As for anticholinesterase drugs, 43.5% of the AD group and 44% of the DLB group were taking them, with no statistically significant difference between the two groups (P=0.943). For antiparkinsonian drugs, only participants in the DLB group benefited, for a total of 38%. The treatments were not interrupted during the research.

There were no significant differences between the groups regarding the occurrence of falls in the previous 6 months. On the other hand, analysis of the participants' profile concerning the recurrence of falls showed that among the participants in the AD group, there were 2 occasional fallers (5%) and 1 recurrent faller (2.5%), in the DLB group, there were 5 occasional fallers (6%) and 7 recurrent fallers (8.3%) and in the HEC group, there were

2 occasional fallers (10%) and no recurrent fallers. The only significant difference between these three groups was a higher number of recurrent fallers in the DLB group than in the HEC group (P=0.006).

Mean performance on the MMSE was poorest in the AD group, with a significant difference with the HEC group (P<0.001) and even with the DLB group (P=0.03).

Mean walking speed was not significantly different between the 3 groups, even when adjusted for age and height, variables known to modify walking speed (DLB group vs. HEC group, P=0.876; AD group vs. HEC group, P=0.187; DLB group vs. AD group P=0.649).

Mean score of the TUG was significantly better in the HEC group when compared to the other two groups (P=0.0001).

On the one-leg balance test, the HEC group had a success rate of 86.4%, which was significantly better than the other two groups (P<0.0001).

We found no correlation between cognitive functions with the MMSE and gait speed, TUG or one-leg balance test in the HEC group. However, there was a correlation between the MMSE and the various gait parameters in the DLB group (gait speed P<0.0001, TUG P<0.0001 and one-leg balance test P=0.004), and for the AD group, there was a correlation between the MMSE and the TUG (P=0.04).

### VBM analysis in DLB group

#### Gray matter volumes

Overall GM volumes differed significantly in pairs between the HEC group (606 +/- 72 ml), the DLB group (554 +/- 82 ml) and the AD group (522 +/- 70 ml).

There was a correlation between total GM volume and cognitive assessment using the MMSE in the AD group (P=0.0001) and the DLB group (P=0.005), but not in the HEC group.

For gait parameters and total GM volume, there was a correlation only for gait speed in the HEC (P=0.04) and DLB groups (P=0.04), but not in the AD group; however, there was no correlation between GM volume and TUG or single-leg balance in any of the groups.

#### Walking speed

For an alpha threshold of 0.05 FWE corrected, we found a relationship between decrease walking speed and bilateral local decrease GM concentration in the caudate nuclei, hippocampi, anterior cingulate cortex (ACC), midcingulate cortex (MCC) and supplementary motor area (SMA), as well as in the right cerebellar cortex and left parietal operculum (PO) (Fig. 2).

The same regions, including the hippocampi, were also found for an alpha threshold of 0.05 FWE corrected when the 12 DLB-AD patients were removed from the analysis.

The walking speed results are summarized in Table 2.
<table><caption>**Table 1** Comparison of demographic, cognitive and motor characteristics between DLB group, AD group and HEC group</caption><thead><tr><th>Characteristics</th><th>DLB group<br>N=84</th><th>AD group<br>N=39</th><th>HEC group<br>N=22</th></tr></thead><tbody><tr><td>Sex Female<br>(ratio)</td><td>0.57<sup>a, c</sup></td><td>0.59<sup>a, b</sup></td><td>0.64<sup>b, c</sup></td></tr><tr><td>Age, years<br>(mean (SD))</td><td>70.6 (10.1)<sup>c</sup></td><td>75.6 (7.6)<sup>a, b</sup></td><td>66.5 (8.7)<sup>c</sup></td></tr><tr><td>Height, cm<br>(mean (SD))</td><td>167 (8.8)<br>N=71/84</td><td>165 (10.6)<br>N=29/39</td><td>165 (8.9)<br>N=19/22</td></tr><tr><td>BMI, kg/m<sup>2</sup><br>(mean (SD))</td><td>27 (4.6)<br>N=71/84</td><td>27.5 (4.6)<br>N=29/39</td><td>25 (4.1)<br>N=19/22</td></tr><tr><td>N</td><td></td><td></td><td></td></tr><tr><td>IADL [0-4]<br>(mean (SD))</td><td>3.2 (1)<sup>a</sup></td><td>3.2 (1.1)<sup>a</sup></td><td>4 (0)</td></tr><tr><td>Antiparkinsonian medication (ratio)</td><td>0.38<sup>a, c</sup></td><td>0</td><td>0</td></tr><tr><td>Cholinesterase inhibitors<br>(ratio)</td><td>0.44</td><td>0.43</td><td>0</td></tr><tr><td>Occasional fallers<br>(ratio)</td><td>0.06</td><td>0.05</td><td>0.1</td></tr><tr><td>Recurrent fallers<br>(ratio)</td><td>0.08<sup>a</sup></td><td>0.025</td><td>0</td></tr><tr><td><strong>Cognitive variables</strong></td><td></td><td></td><td></td></tr><tr><td>Education, years<br>(mean (SD))</td><td>11.3 (4.2)<sup>a</sup><br>N=79/84</td><td>11.8 (4.2)<sup>a</sup><br>N=35/39</td><td>13.5 (2.1)<br>N=20/22</td></tr><tr><td>N</td><td></td><td></td><td></td></tr><tr><td>Laterality, right-handed<br>(ratio)</td><td>0.89</td><td>0.82</td><td>0.95</td></tr><tr><td>MMSE [0-30]<br>(mean (SD))</td><td>25.4 (3.9)<sup>a, c</sup><br>N=84/84</td><td>23.5 (4.4)<sup>a, b</sup><br>N=38/39</td><td>29.1 (0.9)<sup>b, c</sup><br>N=22/22</td></tr><tr><td>N</td><td></td><td></td><td></td></tr><tr><td>Fluctuation score [0-4]<br>(mean (SD))</td><td>1.4 (1.3)<sup>a, c</sup></td><td>0.56 (1.2)<sup>b</sup></td><td>0.27 (0.55)<sup>b</sup></td></tr><tr><td><strong>Motor variables</strong></td><td></td><td></td><td></td></tr><tr><td>Parkinsonism score [0-16]<br>(mean (SD))</td><td>3.6 (1.7)<sup>a, c</sup></td><td>1.2 (0.4)<sup>a, b</sup></td><td>1 (0)<sup>b, c</sup></td></tr><tr><td>Walking speed, m/sec (mean (SD))</td><td>0.87 (1.56)</td><td>0.84 (0.78)</td><td>1.04 (2.5)</td></tr><tr><td>Timed Up and Go test, sec (mean (SD))</td><td>12.5 (6.5)<sup>a</sup></td><td>12.8 (14.5)<sup>a</sup></td><td>7.8 (2.2)<sup>b, c</sup></td></tr><tr><td>One-leg balance<br>(ratio)</td><td>0.41<sup>a</sup></td><td>0.44<sup>a</sup></td><td>0.86<sup>b, c</sup></td></tr></tbody></table>

DLB group, Dementia with Lewy Bodies group; AD group, Alzheimer's Disease group; HEC group, Healthy Elderly Controls group; BMI, Body Mass Index; MMSE, Mini-Mental State Examination; SD Standard Deviation; N: number

The fluctuation score, the total parkinsonism score, the years of education or laterality had no significant effect on our results obtained with walking speed. However, with the covariate MMSE, hippocampi and midcingulate cortex were the only region correlated to walking speed (P=0.05, FWE corrected).

### One-leg balance

A correlation with GM concentration of caudate nuclei, midcingulate cortex and left supplementary motor area was found at the uncorrected threshold of P=0.001 but

did not persist after FWE and FDR correction at the cluster level.

### Timed-Up and go test

No significant results were found at the voxel-wise threshold of 0.05 FWE for TUG. However, using a voxel-wise threshold of P=0.001 uncorrected and then corrected at the cluster level at P=0.05 FDR, we had significant results: the bilateral anterior- and midcingulate cortices, bilateral SMA, left parietal operculum and right cerebellar cortex.

<footnote><sup>a</sup>P < 0.05: versus HEC group</footnote>

<footnote><sup>b</sup>P < 0.05: versus DLB group</footnote>

<footnote><sup>c</sup>P < 0.05: versus AD group</footnote>
<figure><img src="image_5.png" /><figcaption>**Fig. 2** Gray matter concentration correlated to walking speed in dementia with Lewy bodies. Walking speed correlates with bilateral local decrease gray matter concentration in the caudate nuclei, hippocampi, anterior cingulate cortex, midcingulate cortex and supplementary motor area, as well as in the right cerebellar cortex and left parietal operculum (FWE corrected, *P* < 0.05). L: Left; R: Right</figcaption></figure>

<table><caption>**Table 2** Walking speed results with standard covariates in dementia with Lewy bodies</caption><thead><tr><th>Parameter tested</th><th>Regions</th><th>Laterality</th><th>Corrected threshold (FWE)</th><th>Cluster size (k)</th><th>T</th><th>MNI Coordinates (x, y, z in mm)</th></tr></thead><tbody><tr><td rowspan="12">Walking speed</td><td rowspan="2">Hippocampi</td><td>Left</td><td>0.05</td><td>882</td><td>7.49</td><td>-21, -21, -21</td></tr><tr><td>Right</td><td>0.05</td><td>514</td><td>6.58</td><td>21, -10, -24</td></tr><tr><td>Parietal operculum</td><td>Left</td><td>0.05</td><td>265</td><td>6.57</td><td>-40, -27, 22</td></tr><tr><td>Anterior Cingulate Cortex</td><td>Right</td><td>0.05</td><td>146</td><td>5.49</td><td>12, 27, 27</td></tr><tr><td>Midcingulate Cortex</td><td>Right</td><td>0.05</td><td>146</td><td>5.75</td><td>15, 16, 38</td></tr><tr><td rowspan="2">Supplementary Motor Area</td><td>Left</td><td>0.05</td><td>505</td><td>6.89</td><td>-10, 0, 42</td></tr><tr><td>Right</td><td>0.05</td><td>505</td><td>6.07</td><td>-12, -14, 45</td></tr><tr><td rowspan="2">Caudate nuclei</td><td>Left</td><td>0.05</td><td>146</td><td>5.75</td><td>15, 16, 38</td></tr><tr><td>Right</td><td>0.05</td><td>251</td><td>6.05</td><td>-21, 0, 22</td></tr><tr><td rowspan="2">Cerebellum</td><td>Left</td><td>0.05</td><td>185</td><td>5.71</td><td>22, 9, 20</td></tr><tr><td>Right</td><td>0.05</td><td>181</td><td>5.42</td><td>18, -66, -45</td></tr></tbody></table>

By performing these same analyses with walking speed in AD patients, we found a correlation with the bilateral cerebellar cortex at an uncorrected voxel-wise threshold of *P*=0.001 that did not persist after correction at the cluster level (FDR or FWE). We did not find any significant result with TUG and one-leg balance in the AD group. No significant correlations with GM using VBM were found in the HEC group.

Intergroup comparisons were made by adjusting for age, sex and total GM volume.

In the DLB group, compared with the HEC group, there was a decrease in GM concentration in the right temporal pole using a voxel-wise threshold of *P*=0.001 uncorrected and then corrected at the cluster level at *P*=0.05 FDR, without specifically identifying the regions found to be involved in gait disorders in the DLB group (hippocampi, parietal operculum, cingulate cortex, supplementary motor area, caudate nuclei and cerebellum).

Comparing the AD group with the HEC group, it appears that GM concentrations in the temporal poles, hippocampi and amygdala are lower in the AD group

than in the HEC group using a voxel-wise threshold of *P*=0.001 uncorrected and then corrected at the cluster level at *P*=0.05 FDR. Again, the only correlation found for the AD group was between walking speed and cerebellar regions, a correlation that did not persist after correction at the cluster level, and cerebellar regions were not reduced in volume compared with the HEC group.

The AD group compared with the DLB group showed a loss in GM volume in the amygdala and in the anterior part of the hippocampi (*P*=0.05, FWE corrected).

The correlations obtained for the DLB group are therefore not in atrophied areas and therefore appear to be specific to walking.

## Discussion

The aim of this study was to investigate which brain regions were involved in gait disorders of DLB patients compared to participants with AD or to HEC. Volumetric analyses revealed a correlation between reduced walking speed and gray matter decrease in regions expected to be related to motor function: caudate nuclei, cerebellum and
SMA, but the left parietal operculum was also involved (proprioceptive integration). Furthermore, when all covariates were included in the analysis, and in particular the MMSE, the two brain regions most strongly correlated with reduced walking speed were in the limbic regions: cingulate cortex and hippocampi. No such correlation was found for the other two groups.

## Gait speed and cognition

There was a correlation between the MMSE and the various gait parameters in the DLB group, and for the AD group, there was a correlation between the MMSE and the TUG.

Few studies have looked specifically at the impact of cognition on gait parameters in DLB. Sverdrup et al. observed a decline in walking speed across the cognitive spectrum, starting with people with subjective cognitive decline [20]. Participants with mild cognitive impairment also showed a reduction in lower limbs muscle strength, balance and grip strength. Participants with dementia had significantly lower scores on all measures of physical performance. Participants with AD performed better on all assessments, with the exception of grip strength, compared with participants with vascular dementia and DLB.

This corroborates the results obtained in our study with a correlation of the MMSE with the different assessments of the gait parameters in DLB but remaining more discrete in AD with a correlation at the limit of significance only for the TUG.

## Gray matter, cognitive function and gait parameters

This study highlighted a difference in total GM volume between the groups. A decreased volume of GM in AD compared to DLB was expected [21].

There was also a correlation between total GM volume and cognitive assessment using the MMSE in the AD group and the DLB group, but not in the HEC group. This is in agreement with the study by Choi et al. [22], who showed a significant association between GM volumes and MMSE in AD patients with and without Lewy bodies.

Regarding gait parameters and total GM volume, there was a correlation only for gait speed in the HEC and DLB groups, but not in the AD group; however, there was no correlation between GM volume and TUG or single-leg balance in any of the groups.

Lee et al. have shown similar results in a population of healthy older adults [23] and one study examined GM volume in dementia with Lewy bodies and correlated it with double-task walking. In this study, the authors demonstrated that GM volume loss was associated with worse dual-task gait performance compared to single task gait, across cognitively unimpaired controls through and the Lewy body disease spectrum [24]. We found

no previous studies showing a correlation between gait speed and GM volume in AD populations.

## VBM analysis in DLB group

To our knowledge, this is the first study to examine the correlation between walking speed or spatiotemporal gait parameters and GM volume loss in specific brain regions in the DLB population.

Regarding our results on the brain regions involved in reducing walking speed, the limbic region appears to be important. Some authors have found no significant difference in hippocampal volume between patients with AD-DLB and patients with “pure” DLB, even after correction for age and sex [25]. For other authors, DLB is more likely to be characterised by a spared hippocampus [26] but could nevertheless lead to medial temporal lobe atrophy [27]. Loss of hippocampal volume has been shown to lead to memory deficiency but it also appears to be linked to poor walking performance in people with mild cognitive impairment [10, 11]. This relationship between walking speed and the hippocampus could be linked to its involvement in spatial navigation and visual processing [28, 29].

We used the subdivisions of the cingulate cortex proposed by Vogt in 1993. He defined a subdivision into four structures: the ACC, the MCC, the posterior cingulate cortex and the retrosplenic cortex. The anterior and mid-cingulate cortices are part of the limbic system and form the interface between emotions (anterior cortex) and cognition (midcingulate cortex). These cortices integrate data from a variety of sources, including motivation, error evaluation, emotions and cognition. It has been suggested that the anterior part of the midcingulate cortex is used to modulate activity in the executive regions of the brain that direct attention and produce motor responses [30]. This function could therefore play a role in walking speed.

Our results suggest that the limbic system (cingulate cortex and hippocampi) is involved in gait disorders in DLB patients, underlining the existence of a motivational and emotional component responsible for slower walking speed. The correlations found with the hippocampus may be linked to its role in the topographical memory and mental navigation required for walking.

Other studies highlighted the involvement of the cingulate cortex and hippocampus in spatiotemporal gait parameters in healthy older populations. Rosso et al. showed an association between step length variability and GM integrity for the hippocampus and anterior cingulate gyrus as compared to other brain regions indicating a role for cognitive function in motor control [31]. Rosano et al. revealed that shorter steps and longer double support times were associated with smaller sensorimotor regions and also with smaller frontoparietal
regions within the motor, visuospatial, and cognitive pro-
cessing speed domains [32]. The DiSalvio study showed
that greater parahippocampus GM volume was indepen-
dently associated with greater gait speed [33]. Finally, in
a population of older adults with amnestic mild cognitive
impairment, McGough et al. found a moderate positive
correlation between hippocampal and anterior cingulate
volumes and gait and executive functions [34].

Caudate nuclei is divided into two parts according to its
functions and connectivities : a dorsal part, involved in
motor skills and cognitive functions [35] and implicated
in spatial working memory [36], and a ventral part, which
is more associated with the treatment of rewards, affects
such as pain and even fatigue [37]. Allali et al. showed in
older people without neurocognitive disorders that brain
regions differed according to walking conditions and that
three main individual GM regions were positively corre-
lated with walking speed: right thalamus, right caudate
nucleus, and left middle frontal gyrus for normal walking,
rapid walking, and dual-task walking condition, respec-
tively [38]. A correlation between attention and process-
ing speed disorders and the caudate nuclei has also been
demonstrated [39, 40]. Moreover using the same cohort
as for this study, we have demonstrated that the decrease
of cognitive speed processing in DLB was correlated with
caudate nuclei [41]. This could mean that the caudate
nuclei underlie overall brain processing speed, both cog-
nitive and physical in DLB patients.

In the DLB group, there was a significant correlation
with the cerebellum GM concentration probably due
to its role in motor cognitive control, motor program-
ming and motor coordination [42, 43]. We also found
the involvement of the left parietal operculum, which
persisted when we took laterality as a covariate. The pari-
etal operculum is a structure located in the lower part of
the parietal lobe, above the insula, in which the second-
ary somatosensory cortex is located [44]. This cortex is
believed to be involved in pain perception, tactile atten-
tion, visceral sensations, but also, attention to the spatial
location of an object and intentional motor behaviour,
which may be involved in walking [44]. This cerebral
region has, therefore, connections to the parietal percep-
tual network as well as to the motor frontal areas [45].
Finally, concerning the SMA, a link has been demon-
strated in planning and execution of simple to complex
motor tasks [46]. Some authors have also shown a func-
tional connectivity between the MCC and motor frontal
regions [47], particularly with the primary motor cortex
and the SMA, making this cingulate region an area of
intentional motor control [48], at a higher level than the
SMA [49].

Walking disorders in patients with DLB are multifac-
torial. The extrapyramidal syndrome obviously plays
a part in these disorders but does not appear to be the

only factor involved. In fact, our study shows that these
gait disorders, and particularly a slower walking speed,
appear to be linked to a reduction in the volume of GM
in structures involved in cognitive, spatial navigation,
motivational, motor control with processing speed and
balance, independently of cognitive fluctuations and the
parkinsonism score.

Limitations section

Several limitations need to be considered. This was a
cross-sectional study, which did not allow us to assess
the temporal direction of the associations. However, our
analysis benefited from the fact that it was conducted in
a well-characterized cohort with clearly established diag-
noses, and that the DLB cohort was compared with the
other two groups of patients. This enabled us to adjust for
several potential confounding factors.

There is probably a lack of power in the HEC group,
given the limited number of subjects. For the AD group,
we cannot exclude the same problem. However, given
the limited number of articles published on this subject,
the number of participants to be included was impos-
sible to calculate in advance. On the other hand, with
almost 40 participants presenting with AD, and given the
significant cerebral atrophy visualized on MRI if there
were significant differences they should have been high-
lighted. Furthermore, similar studies on other character-
istics have shown correlations with an equivalent or even
smaller number of participants [50–53].

It is difficult to obtain accurate data on the number of
falls in this older population suffering from neurocogni-
tive disorders, as there is a reporting bias with a risk of
forgetting the number of falls and a willingness to under-
estimate it. However, it was possible to determine the
profile of patients who fall (occasional or recurrent) fairly
easily.

We studied gait disorders only in association with GM
density. Other brain imaging parameters should be evalu-
ated to better understand the neural correlates associated
with gait speed in the DLB population (perfusion with
arterial spin labeling, functional connectivity with func-
tional MRI, anatomical connectivity with diffusion tensor
imaging).

Conclusion

We describe here for the first time the neural basis of
walking speed in DLB. Indeed, there is a motivational and
emotional component in voluntary walking in subjects
with DLB, underpinned by the cingulate cortex, a spatial
orientation component, underpinned by hippocampi,
as well as the involvement of cerebral processing speed
and extrapyramidal circuit, underpinned by the caudate
nuclei. This work should be completed by a study of the
anatomical and functional connectivity between all these
structures in order to identify brain networks responsible for gait disorders in DLB.

### Abbreviations

<table><tr><td>ACC</td><td>Anterior Cingulate Cortex</td></tr><tr><td>AD</td><td>Alzheimer's Disease</td></tr><tr><td>ADL</td><td>Activities of Daily Living</td></tr><tr><td>ANOVA</td><td>Analysis Of Variance</td></tr><tr><td>CM2R</td><td>Memory Resource and Research Center</td></tr><tr><td>DARTEL</td><td>Diffeomorphic Anatomical Registration Through Exponentiated Lie algebra</td></tr><tr><td>DLB</td><td>Dementia with Lewy bodies</td></tr><tr><td>FDR</td><td>False Discovery Rates</td></tr><tr><td>FWE</td><td>Family-Wise Error GM: Gray Matter</td></tr><tr><td>HEC</td><td>Healthy Elderly Controls</td></tr><tr><td>IADL</td><td>Instrumental Activities of Daily Living</td></tr><tr><td>MCC</td><td>MidCingulate Cortex</td></tr><tr><td>MMSE</td><td>Mini-Mental State Examination</td></tr><tr><td>MNI</td><td>Montreal Neurological Institute</td></tr><tr><td>MRI</td><td>Magnetic Resonance Imaging</td></tr><tr><td>PO</td><td>Parietal Operculum</td></tr><tr><td>SD</td><td>Standard Deviation</td></tr><tr><td>SMA</td><td>Supplementary Motor Area</td></tr><tr><td>SPM12</td><td>Statistical Parametric Mapping 12</td></tr><tr><td>TUG</td><td>Timed Up and Go test</td></tr><tr><td>UPDRS III</td><td>Unified Parkinson's Disease Rating Scale III</td></tr><tr><td>VBM</td><td>Voxel-Based-Morphometry</td></tr></table>

### Acknowledgements

We are grateful to the patients and the control subjects for their participation in the study.

### Author contributions

AS-C and ES: design of the research project, acquisition of data, execution of the statistical analysis, drafting of the manuscript. LL: execution of research project and statistical analysis, revision of manuscript. AB: organisation and execution of the research project. LR: organisation and execution of the research project. CD: execution of the research project. NP: execution of the research project, revision of the manuscript. PLDS: execution of the research project, revision of the manuscript. CM: execution of the research project. BC: execution of the research project. CM-H: execution of the research project. FB: design of research project, revision of statistical analysis, drafting and revision of the manuscript. All authors read and approved the final manuscript.

### Funding

This work was funded by PHRC Interégional.

### Data availability

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

### Declarations

#### Ethics approval and consent to participate

The study was approved by the local Ethics Committee (Comité de Protections des Personnes, Est IV, Strasbourg, France), and all experiments were performed according to the guidelines and regulations provided by this committee. Controls and patients gave written informed consent to participate in the study.

#### Consent for publication

Not applicable.

#### Competing interests

The authors declare no competing interests.

Received: 21 March 2024 / Accepted: 19 July 2024

Published online: 30 July 2024

### References

1. Niu H, Álvarez-Álvarez I, Guillén-Grima F, Aguinaga-Ontoso I. Prevalence and incidence of Alzheimer's disease in Europe: a meta-analysis. Neurologia Oct. 2017;32(8):523-32.

2. McKeith I. Dementia with Lewy bodies. Dialogues Clin Neurosci Sept. 2004;6(3):333-41.

3. Nelson PT, Jicha GA, Kryscio RJ, Abner EL, Schmitt FA, Cooper G, et al. Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J Neurol mars. 2010;257(3):359-66.

4. Allan LM, Ballard CG, Rowan EN, Kenny RA. Incidence and prediction of falls in dementia: a prospective study in older people. PLoS ONE. 2009;4(5):e5521.

5. Ballard CG, Shaw F, Lowery K, McKeith I, Kenny R. The prevalence, assessment and associations of falls in dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord. 1999;10(2):97-103.

6. Morris JC, Rubin EH, Morris EJ, Mandel SA. Senile dementia of the Alzheimer's type: an important risk factor for serious falls. J Gerontol Juill. 1987;42(4):412-7.

7. Fritz NE, Kegelmeyer DA, Kloos AD, Linder S, Park A, Kataki M, et al. Motor performance differentiates individuals with Lewy body dementia, Parkinson's and Alzheimer's disease. Gait Posture oct. 2016;50:1-7.

8. Mc Ardle R, Morris R, Wilson J, Galna B, Thomas AJ, Rochester L. What Can Quantitative Gait Analysis Tell Us about Dementia and its subtypes? A structured review. J Alzheimers Dis. 2017;60(4):1295-312.

9. Barkhof F, Polvikoski TM, van Straaten ECW, Kalaria RN, Sulkava R, Aronen HJ, et al. The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old. Neurol 9 oct. 2007;69(15):1521-7.

10. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol août. 2007;6(8):734-46.

11. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, et al. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol Nov. 2010;9(11):1118-27.

12. Zhong J, Pan P, Dai Z, Shi H. Voxelwise meta-analysis of gray matter abnormalities in dementia with Lewy bodies. Eur J Radiol oct. 2014;83(10):1870-4.

13. Colloby SJ, McParland S, O'Brien JT, Attems J. Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias. Brain sept. 2012;135(Pt 9):2798-808.

14. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurol 27 déc. 2005;65(12):1863-72.

15. Cockrell JR, Folstein MF. Mini-mental State Examination (MMSE). Psychopharmacol Bull. 1988;24(4):689-92.

16. Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord Juill. 2003;18(7):738-50.

17. Bohannon RW. Comfortable and maximum walking speed of adults aged 20-79 years: reference values and determinants. Age Ageing janv. 1997;26(1):15-9.

18. Vellas BJ, Wayne SJ, Romero L, Baumgartner RN, Rubenstein LZ, Garry PJ. One-leg balance is an important predictor of injurious falls in older persons. J Am Geriatr Soc juin. 1997;45(6):735-8.

19. Podsiadlo D, Richardson S. The timed « up & go »: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc févr. 1991;39(2):142-8.

20. Sverdrup K, Selbæk G, Bergh S, Strand BH, Thingstad P, Skjellegrind HK, et al. Physical performance across the cognitive spectrum and between dementia subtypes in a population-based sample of older adults: the HUNT study. Archives Gerontol Geriatr Juill. 2021;95:104400.

21. Watson R, O'Brien JT, Barber R, Blamire AM. Patterns of gray matter atrophy in dementia with Lewy bodies: a voxel-based morphometry study. Int Psychogeriatr avr. 2012;24(4):532-40.

22. for the Alzheimer's Disease Research Center, Choi SH, Olabarrieta M, Lopez OL, Maruca V, DeKosky ST, et al. Gray Matter Atrophy Associated with Extra-pyramidal signs in the Lewy body variant of Alzheimer's Disease. JAD 14 nov. 2012;32(4):1043-9.

23. Lee S, Kim EY, Shin C. Longitudinal association between brain volume change and gait speed in a general population. Experimental Gerontol avr. 2019;118:26-30.

24. Subotic A, Gee M, Nelles K, Ba F, Dadar M, Duchesne S et al. oct. Gray matter loss relates to dual task gait in Lewy body disorders and aging. J Neurol 30 2023.

25. van der Zande JJ, Steenwijk MD, Ten Kate M, Wattjes MP, Scheltens P, Lemstra AW. Gray matter atrophy in dementia with Lewy bodies with and
without concomitant Alzheimer's disease pathology. Neurobiol Aging Nov. 2018;71:171-8.

26. Oppedal K, Ferreira D, Cavallin L, Lemstra AW, Ten Kate M, Padovani A, et al. A signature pattern of cortical atrophy in dementia with Lewy bodies: a study on 333 patients from the European DLB consortium. Alzheimers Dement mars. 2019;15(3):400-9.

27. Blanc F, Colloby SJ, Philippi N, de Pétigny X, Jung B, Demuynck C, et al. Cortical thickness in dementia with Lewy Bodies and Alzheimer's Disease: a comparison of Prodromal and Dementia stages. PLoS ONE. 2015;10(6):e0127396.

28. Turk-Browne NB. The hippocampus as a visual area organized by space and time: a spatiotemporal similarity hypothesis. Vis Res déc. 2019;165:123-30.

29. Eichenbaum H. The role of the hippocampus in navigation is memory. J Neurophysiol 1 avr. 2017;117(4):1785-96.

30. Rolls ET. The cingulate cortex and limbic systems for emotion, action, and memory. Brain Struct Funct déc. 2019;224(9):3001-18.

31. Rosso AL, Olson Hunt MJ, Yang M, Brach JS, Harris TB, Newman AB, et al. Higher step length variability indicates lower gray matter integrity of selected regions in older adults. Gait Posture. 2014;40(1):225-30.

32. Rosano C, Aizenstein H, Brach J, Longenberger A, Studenski S, Newman AB. Special article: gait measures indicate underlying focal gray matter atrophy in the brain of older adults. J Gerontol Biol Sci Med Sci déc. 2008;63(12):1380-8.

33. DiSalvio NL, Rosano C, Aizenstein HJ, Redfern MS, Furman JM, Jennings JR, et al. Gray Matter regions Associated with Functional mobility in Community-Dwelling older adults. J Am Geriatr Soc mai. 2020;68(5):1023-8.

34. McGough EL, Kelly VE, Weaver KE, Logsdon RG, McCurry SM, Pike KC, et al. Limbic and basal ganglia neuroanatomical correlates of Gait and executive function: older adults with mild cognitive impairment and Intact Cognition. Am J Phys Med Rehabil avr. 2018;97(4):229-35.

35. Robinson JL, Laird AR, Glahn DC, Blangero J, Sanghera MK, Pessoa L, et al. The functional connectivity of the human caudate: an application of meta-analytic connectivity modeling with behavioral filtering. Neuroimage mars. 2012;60(1):117-29.

36. Postle BR, D'Esposito M. Dissociation of human caudate nucleus activity in spatial and nonspatial working memory: an event-related fMRI study. Brain Res Cogn Brain Res 16 Juil. 1999;8(2):107-15.

37. Miller AH, Jones JF, Drake DF, Tian H, Unger ER, Pagnoni G. Decreased basal ganglia activation in subjects with chronic fatigue syndrome: association with symptoms of fatigue. PLoS ONE. 2014;9(5):e98156.

38. Allali G, Montembeault M, Brambati SM, Bherer L, Blumen HM, Launay CP, et al. Brain structure Covariance Associated with Gait Control in Aging. J Gerontol Biol Sci Med Sci 23 avr. 2019;74(5):705-13.

39. Derauf C, Lester BM, Neyzi N, Kekatpure M, Gracia L, Davis J, et al. Subcortical and cortical structural central nervous system changes and attention processing deficits in preschool-aged children with prenatal methamphetamine and tobacco exposure. Dev Neurosci. 2012;34(4):327-41.

40. Spies G, Ahmed-Leitao F, Fennema-Notestine C, Cherner M, Seedat S. Effects of HIV and childhood trauma on brain morphometry and neurocognitive function. J Neurovirol avr. 2016;22(2):149-58.

41. Botzung A, Philippi N, Noblet V, Loureiro de Sousa P, Blanc F. Pay attention to the basal ganglia: a volumetric study in early dementia with Lewy bodies. Alzheimers Res Ther 21 déc. 2019;11(1):108.

42. Proville RD, Spolidoro M, Guyon N, Dugué GP, Selimi F, Isope P, et al. Cerebellum involvement in cortical sensorimotor circuits for the control of voluntary movements. Nat Neurosci sept. 2014;17(9):1233-9.

43. Sokolov AA, Miall RC, Ivry RB. The Cerebellum: adaptive prediction for Movement and Cognition. Trends Cogn Sci Mai. 2017;21(5):313-32.

44. Eickhoff SB, Schleicher A, Zilles K, Amunts K. The human parietal operculum. I. Cytoarchitectonic mapping of subdivisions. Cereb Cortex févr. 2006;16(2):254-67.

45. Eickhoff SB, Jbabdi S, Caspers S, Laird AR, Fox PT, Zilles K, et al. Anatomical and functional connectivity of cytoarchitectonic areas within the human parietal operculum. J Neurosci 5 mai. 2010;30(18):6409-21.

46. Hupfeld KE, Ketcham CJ, Schneider HD. Transcranial direct current stimulation (tDCS) to the supplementary motor area (SMA) influences performance on motor tasks. Exp Brain Res mars. 2017;235(3):851-9.

47. Amiez C, Petrides M. Neuroimaging evidence of the anatomo-functional organization of the human cingulate motor areas. Cereb Cortex mars. 2014;24(3):563-78.

48. Paus T. Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nat Rev Neurosci juin. 2001;2(6):417-24.

49. Asemi A, Ramaseshan K, Burgess A, Diwadkar VA, Bressler SL. Dorsal anterior cingulate cortex modulates supplementary motor area in coordinated unimanual motor behavior. Front Hum Neurosci. 2015;9:309.

50. Son JH, Han DH, Min KJ, Kee BS. Correlation between gray matter volume in the temporal lobe and depressive symptoms in patients with Alzheimer's disease. Neurosci Lett août. 2013;548:15-20.

51. Liu S, Zhang Y, Peng B, Pang C, Li M, Zhu J, et al. Correlation between parameters related to Sarcopenia and gray matter volume in patients with mild to moderate Alzheimer's disease. Aging Clin Exp Res 19 sept. 2022;34(12):3041-53.

52. Galli A, Pilotto A, Chiarini B, Giunta M, Corbo D, Tirloni C, et al. Occipital atrophy signature in prodromal Lewy bodies disease. Alz Dem Diag Ass Dis Mo Oct. 2023;15(4):e12462.

53. Tisserand A, Cretin B, Mondino M, Botzung A, Sanna L, Demuynck C, et al. Neural correlates of photophobia in prodromal and mild dementia with Lewy bodies. Euro J Neurol août. 2023;30(8):2215-21.

## Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.